Dyno Therapeutics operates at the intersection of artificial intelligence and molecular biology, developing high-performance gene delivery technologies. The company applies AI-powered capsid engineering to advance genetic medicine and gene therapy, a field demanding precise biological design at scale.
The work spans several technical domains, including artificial intelligence, molecular biology, capsid engineering, and gene delivery. This multidisciplinary approach is fundamental to the company's mission of building next-generation therapies.
Internally, the company emphasizes intellectual rigor, scientific curiosity, and a commitment to its mission. Team members, referred to as "AAViators," are encouraged to be bold thinkers who embrace the scientific process and pursue ambitious goals. The culture values adaptability, the courage to speak hard truths, and a relentless pursuit of excellence.
